Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) levels in adults with type 2 diabetes mellitus. This treatment is commonly recommended as part of a medically supervised diabetes management plan to help patients maintain healthier glucose control and support long-term wellness.
Mounjaro is prescribed for adults diagnosed with type 2 diabetes mellitus. It is used together with proper nutrition, healthy lifestyle habits, and regular physical activity to improve blood sugar control. The treatment is administered through injection and should only be used under professional medical guidance.
It is not known if Mounjaro can be used in people who have had pancreatitis. Patients with a history of pancreatitis should consult their healthcare provider before starting treatment to determine whether this medication is suitable for their condition.
Mounjaro is not for use in people with type 1 diabetes. This medication is specifically intended for adults with type 2 diabetes mellitus and should not be considered a replacement for insulin therapy.
It is not known if Mounjaro is safe and effective for use in children under 18 years of age. The treatment is currently intended for adult patients only unless otherwise advised by a qualified healthcare professional.
Serious allergic reactions may occur in some individuals using Mounjaro. Stop using Mounjaro and seek medical help immediately if you experience symptoms of a serious allergic reaction.
Kidney problems, including kidney failure, may occur in some people using Mounjaro. In patients who already have kidney-related conditions, side effects such as diarrhea, nausea, and vomiting may lead to dehydration, which can worsen kidney problems.
It is important to drink enough fluids during treatment to help reduce the risk of dehydration and support overall kidney health. Patients experiencing ongoing symptoms should contact their healthcare provider for medical advice and monitoring.
Ready to take the next step?
Book a free consultation with our specialist surgeons.
Book an Appointment +971 55 556 3455Mounjaro (tirzepatide) is an injectable medication used for weight management and glycemic control in individuals with obesity or type 2 diabetes. It mimics the effects of two hormones, GLP-1 and GIP, which help regulate appetite and glucose metabolism.
Mounjaro works by stimulating insulin secretion in response to meals, reducing appetite, and slowing gastric emptying. This combination helps individuals eat less and lose weight while improving blood sugar control.
Good candidates include adults with a BMI of 30 or higher (obesity) or a BMI of 27 or higher with related health conditions, such as hypertension or high cholesterol. Candidates should be in good health and have realistic expectations about weight loss outcomes.
Mounjaro is administered via subcutaneous injection (under the skin) once a week. The injection can be given in the abdomen, thigh, or upper arm.
The actual injection process takes only a few minutes. However, the overall session may last longer if a consultation or assessment is included.
